WW International (WW) said Tuesday that it has redesigned its application and digital platform to include support for members who use GLP-1 medications for weight loss.
The company said the new GLP-1 Success program provides nutrition guidance, tools to track weight loss and medication doses, strategies for managing side effects, among others.
The firm said its redesigned app will be available in Canada in early January 2026.
Shares were up more than 6% in recent trading.
Price: 25.90, Change: +1.62, Percent Change: +6.65
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments